Pitango Venture Capital, one of the largest venture capital firms in Israel, announced the first closing of a new $175 million healthcare technology fund. With the new fund, the firm plans to build a portfolio of approximately 15 new companies over a period of three to four years.
UltraSight, based in Israel, recently received a nod from the FDA to market its UltraSight AI Guidance product that can assist medical professionals without sonography experience in acquiring cardiac ultrasound images and allow for more widespread detection of heart diseases.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Israeli health tech fund Shoni Health Ventures recently launched to invest in digital health and medical device startups that are in the pre-seed and seed stages of fundraising. The fund is affiliated with Sheba Medical Center, the largest hospital in Israel. Startups will have access to the hospital’s innovation center so that they can develop, pilot and commercialize their products.
NeuraLight just raised $25 million in its bid to create new, digital endpoints that can be used by clinicians and researchers to objectively measure neurological conditions with the ultimate goal - still several years away - to have the company's technology serve as the gold standard for neurological evaluation.
A new startup initiative in Israel aims to create and invest in startups that use artificial intelligence to address challenges in drug discovery and development. Called AION Labs, this innovation lab stems from an economic development effort from the Israeli government and will have contributions from AstraZeneca, Merck, Pfizer and Teva Pharmaceutical.
The company offers clinical triage via an artificial intelligence-powered chatbot and unlimited virtual visits through a majority of its plans. Inspired by the Israeli healthcare system, patients on Antidote plans pay a monthly membership fee.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
A new telehealth company, called Antidote, is taking aim at rising healthcare costs in the U.S. by providing an alternative inspired by the healthcare system in Israel. For a monthly membership fee, Antidote users gain unlimited virtual visits and zero copays on most medications.
Tel Aviv-based Ibex Medical Analytics published data on what it called the first algorithm to go beyond detection and into areas like tumor grading and sizing.
The company, based near Tel Aviv, said it plans to invest money from the fund, Arkin Bio-Ventures II, in areas like gene therapy, as well as RNA- and DNA-targeted drugs.
K Health, a startup that lets patients look up their symptoms and chat with a doctor, raised $48 million in funding.
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
With the regulatory nod, Sight Diagnostics can have its computer-vision powered blood analyzer be sold to hospital labs to provide lab-grade results within 10 minutes on just two drops of blood.
The algorithm — which measures variations in heart rate — is designed to predict heart problems, but a cardiologist wonders whether it can outperform other risk factors.
The Israeli maker of FDA-cleared medical devices announced it has expanded its partnership with Best Buy such that its connected device kit - TytoHome - is sold in the retailer's U.S. locations.
89Bio, a biopharma company developing a drug to treat NASH, went public on Monday and saw its stock increase beyond the $16 per share it had opened with.
This is the fourth fund launched by Accelmed, a group of funds based in Israel and New York, which currently manages more than $300 million.